A FDA vaccine advisory committee meeting scheduled for March to select the strains to be included in next season's flu shot has been canceled. Federal health officials notified members of the Vaccines and Related Biological Products Advisory Committee of the cancelation in an email Wednesday afternoon, says committee member Dr. Paul Offit, the director of the Vaccine Education Center at Children’s Hospital of Philadelphia.
